Health Product Shortages homepage

Welcome to Health Product Shortages Canada, the website for mandatory reporting of health product shortages and discontinuations by regulated parties. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the health products they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca (opens in new window).

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

List of shortage reports
Brand name Company Name Status Strength Update Date Updated View Report
MYCOPHENOLATE MOFETIL FOR INJECTION, USP ACCORD HEALTHCARE INC Resolved 500MG Updated Report 2026-02-09 207554
METHOTREXATE INJECTION BP ACCORD HEALTHCARE INC Resolved 25MG Updated Report 2026-02-09 225235
IRINOTECAN HYDROCHLORIDE INJECTION USP ACCORD HEALTHCARE INC Resolved 20MG Updated Report 2026-02-09 223399
IRINOTECAN HYDROCHLORIDE INJECTION USP ACCORD HEALTHCARE INC Resolved 20MG Updated Report 2026-02-09 223404
ACH-METHOTREXATE ACCORD HEALTHCARE INC Actual shortage 2.5MG Updated Report 2026-02-09 254876
ACH-FINASTERIDE ACCORD HEALTHCARE INC Resolved 5MG Updated Report 2026-02-09 229914
ACH-ALENDRONATE ACCORD HEALTHCARE INC Actual shortage 70MG Updated Report 2026-02-09 216767
ACH-BICALUTAMIDE ACCORD HEALTHCARE INC Resolved 50MG Updated Report 2026-02-09 251375
MINT-GABAPENTIN MINT PHARMACEUTICALS INC Actual shortage 400MG New Report 2026-02-09 277609
MINT-GABAPENTIN MINT PHARMACEUTICALS INC Actual shortage 300MG Updated Report 2026-02-09 277605

Discontinuation Reports

List of discontinuation reports
Brand name Company Name Status Strength Update Date Updated View Report
ADCIRCA ELI LILLY CANADA INC To be discontinued 20MG New Report 2026-02-06 277590
HUMIRA ABBVIE CORPORATION To be discontinued 40MG New Report 2026-02-04 277251
SORIATANE ALLERGAN INC To be discontinued 25MG New Report 2026-02-03 277223
SORIATANE ALLERGAN INC To be discontinued 10MG New Report 2026-02-03 277220
BEZALIP SR ALLERGAN INC To be discontinued 400MG New Report 2026-02-03 277216
Get it on Google Play Download on the App Store